☰

JoEllen Welsh - Publications

Affiliations: 
University of Ottawa, Ottawa, ON, Canada 
 University of Notre Dame, Notre Dame, IN, United States 
 State University of New York, Albany, Albany, NY, United States 
Area:
Medicine and Surgery, Pathology, Pharmacology, Oncology, Cell Biology
Website:
https://www.albany.edu/sph/faculty/joellen-welsh
Tree Info Grants Similar researchers PubMed Report error

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Narvaez CJ, Bak MJ, Salman N, Welsh J. Vitamin K2 enhances the tumor suppressive effects of 1,25(OH)D in triple negative breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 231: 106307. PMID 37030416 DOI: 10.1016/j.jsbmb.2023.106307  0.548
2022 Welsh J, Bak MJ, Narvaez CJ. New insights into vitamin K biology with relevance to cancer. Trends in Molecular Medicine. PMID 36028390 DOI: 10.1016/j.molmed.2022.07.002  0.347
2021 Welsh J. Vitamin D and Breast Cancer: Mechanistic Update. Jbmr Plus. 5: e10582. PMID 34950835 DOI: 10.1002/jbm4.10582  0.65
2021 Bouillon R, Haussler M, Bikle D, Christakos S, Welsh J. Introduction: Special Issue on Vitamin D Dedicated to the Memory of Anthony W Norman. Jbmr Plus. 5: e10445. PMID 33553991 DOI: 10.1002/jbm4.10445  0.448
2020 Narvaez CJ, LaPorta E, Robilotto S, Liang J, Welsh J. Inhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D in breast cancer. Oncotarget. 11: 2889-2905. PMID 32774770 DOI: 10.18632/Oncotarget.27587  0.687
2020 Guizzardi S, Picotto G, Rodriguez V, Welsh J, Narvaez C, Bohl L, Tolosa de Talamoni N. Combined treatment of menadione and calcitriol increases the antiproliferative effect by promoting oxidative/nitrosative stress, mitochondrial dysfunction, and autophagy in breast cancer MCF-7 cells. Canadian Journal of Physiology and Pharmacology. 98: 548-556. PMID 32762631 DOI: 10.1139/Cjpp-2019-0585  0.467
2020 DeSantis KA, Robilotto SL, Matson M, Kotb NM, Lapierre CM, Minhas Z, Leder AA, Abdul K, Facteau EM, Welsh J. VDR in Salivary Gland Homeostasis and Cancer. The Journal of Steroid Biochemistry and Molecular Biology. 105600. PMID 31958633 DOI: 10.1016/j.jsbmb.2020.105600  0.628
2019 Beaudin S, Kokabee L, Welsh J. Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells. Oncotarget. 10: 2292-2305. PMID 31040920 DOI: 10.18632/Oncotarget.26765  0.337
2019 Fleet JC, Campbell MJ, Carlberg C, Demay MB, Ebeling PR, Schoenmakers I, White J, Welsh J, Hewison M. Highlights from the 21th Workshop on Vitamin D in Barcelona, May 2018. The Journal of Steroid Biochemistry and Molecular Biology. PMID 30926426 DOI: 10.1016/j.jsbmb.2019.03.026  0.559
2019 Zhang P, Schatz A, Adeyemi B, Kozminski D, Welsh J, Tenniswood M, Wang WW. Vitamin D and Testosterone Co-ordinately Modulate Intracellular Zinc Levels and Energy Metabolism in Prostate Cancer Cells. The Journal of Steroid Biochemistry and Molecular Biology. PMID 30664926 DOI: 10.1016/J.Jsbmb.2019.01.006  0.587
2018 Kokabee L, Beaudin S, Welsh J. Abstract 5170: The effect of vitamin K on aggressiveness, lipid metabolism and gene expression in triple-negative breast cancer cells Cancer Research. 78: 5170-5170. DOI: 10.1158/1538-7445.Am2018-5170  0.504
2018 Trevizo-Barresi BG, Welsh J. Abstract 4037: Interactions between STAT3 and TGFβ in the regulation of hyaluronic acid synthesis and signaling in immortalized human mammary epithelial cells Cancer Research. 78: 4037-4037. DOI: 10.1158/1538-7445.Am2018-4037  0.39
2018 Narvaez CJ, Balinth S, Welsh J. Abstract 3742: Vitamin D inhibits hyaluronan synthesis and extracellular matrix gene expression in triple negative breast cancer Cancer Research. 78: 3742-3742. DOI: 10.1158/1538-7445.Am2018-3742  0.631
2017 Hewison M, Fleet JC, Demay MB, Christakos S, Bouillon R, Welsh J, White JH. Highlights from the 20th Workshop on Vitamin D in Orlando, Mar. 28-31, 2017. The Journal of Steroid Biochemistry and Molecular Biology. PMID 29180166 DOI: 10.1016/J.Jsbmb.2017.11.010  0.631
2017 Beaudin S, Welsh J. 1,25-Dihydroxyvitamin D regulation of glutamine synthetase and glutamine metabolism in human mammary epithelial cells. Endocrinology. PMID 29029014 DOI: 10.1210/En.2017-00238  0.645
2017 Christakos S, White JH, Hewison M, Welsh J, Lips P, Bouillon R, Demay MB. Highlights from the 19(th) Workshop on Vitamin D in Boston, March 29-31, 2016. The Journal of Steroid Biochemistry and Molecular Biology. 173: 1-4. PMID 28895872 DOI: 10.1016/j.jsbmb.2017.06.005  0.558
2017 Welsh J. Vitamin D and Breast Cancer: Past and Present. The Journal of Steroid Biochemistry and Molecular Biology. PMID 28746837 DOI: 10.1016/J.Jsbmb.2017.07.025  0.699
2017 Welsh J. Function of the vitamin D endocrine system in mammary gland and breast cancer. Molecular and Cellular Endocrinology. PMID 28579119 DOI: 10.1016/J.Mce.2017.04.026  0.733
2017 Welsh J, Beaudin S, Tenniswood M. Abstract P5-05-04: Vitamin K dependent gamma-carboxylation in breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-05-04  0.42
2016 Lips P, Welsh J, Demay M, Bouillon R. Highlights from the 18th workshop on vitamin D, Delft, The Netherlands, April 21-24, 2015. The Journal of Steroid Biochemistry and Molecular Biology. 164: 1-3. PMID 27969101 DOI: 10.1016/J.Jsbmb.2016.10.005  0.63
2016 Alimirah F, Peng X, Gupta A, Yuan L, Welsh J, Cleary M, Mehta RG. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells. Experimental Cell Research. PMID 27693451 DOI: 10.1016/J.Yexcr.2016.08.012  0.388
2016 Beaudin S, Welsh J. 1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells. Molecular and Cellular Endocrinology. 424: 34-41. PMID 26774511 DOI: 10.1016/J.Mce.2016.01.011  0.488
2015 Matthews DG, D'Angelo J, Drelich J, Welsh J. Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density. The Journal of Steroid Biochemistry and Molecular Biology. PMID 26429395 DOI: 10.1016/J.Jsbmb.2015.09.035  0.445
2015 Simmons KM, Beaudin SG, Narvaez CJ, Welsh J. Gene Signatures of 1,25-Dihydroxyvitamin D3 Exposure in Normal and Transformed Mammary Cells. Journal of Cellular Biochemistry. 116: 1693-711. PMID 25736056 DOI: 10.1002/Jcb.25129  0.655
2015 Welsh J, Bikle DD, Lips P. Highlights from the 17th workshop on vitamin D, Chicago, IL, June 17-21, 2014. The Journal of Steroid Biochemistry and Molecular Biology. 148: 1-2. PMID 25641118 DOI: 10.1016/J.Jsbmb.2015.01.024  0.499
2015 Beaudin SG, Robilotto S, Welsh J. Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 148: 96-102. PMID 25239595 DOI: 10.1016/j.jsbmb.2014.09.014  0.568
2014 Narvaez CJ, Matthews D, LaPorta E, Simmons KM, Beaudin S, Welsh J. The impact of vitamin D in breast cancer: genomics, pathways, metabolism. Frontiers in Physiology. 5: 213. PMID 24982636 DOI: 10.3389/Fphys.2014.00213  0.692
2014 Rhieu SY, Annalora AJ, LaPorta E, Welsh J, Itoh T, Yamamoto K, Sakaki T, Chen TC, Uskokovic MR, Reddy GS. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1. Journal of Cellular Biochemistry. 115: 1392-402. PMID 24535953 DOI: 10.1002/Jcb.24789  0.688
2014 LaPorta E, Welsh J. Modeling vitamin D actions in triple negative/basal-like breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 144: 65-73. PMID 24239860 DOI: 10.1016/J.Jsbmb.2013.10.022  0.677
2014 Keith ME, LaPorta E, Welsh J. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling. Molecular Carcinogenesis. 53: 286-99. PMID 23681781 DOI: 10.1002/Mc.21975  0.692
2014 Helle J, Zierau O, Kräker K, Keiler A, Vollmer G, Welsh J, Kretzschmar G. Abstract 625: Proliferative effects of the phytoestrogens 8-Prenylnaringenin, 6-(1.1-dimethylallyl)naringenin and Naringenin in MCF-7 cells and the rat mammary gland Cancer Research. 74: 625-625. DOI: 10.1158/1538-7445.Am2014-625  0.38
2013 Milani C, Katayama ML, de Lyra EC, Welsh J, Campos LT, Brentani MM, Maciel Mdo S, Roela RA, del Valle PR, Góes JC, Nonogaki S, Tamura RE, Folgueira MA. Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. Bmc Cancer. 13: 119. PMID 23497279 DOI: 10.1186/1471-2407-13-119  0.6
2013 Wang WL, Welsh J, Tenniswood M. 1,25-Dihydroxyvitamin D3 modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA. The Journal of Steroid Biochemistry and Molecular Biology. 136: 247-51. PMID 23059473 DOI: 10.1016/J.Jsbmb.2012.09.033  0.499
2013 Bikle DD, Elalieh H, Welsh J, Oh D, Cleaver J, Teichert A. Protective role of vitamin D signaling in skin cancer formation. The Journal of Steroid Biochemistry and Molecular Biology. 136: 271-9. PMID 23059470 DOI: 10.1016/J.Jsbmb.2012.09.021  0.573
2013 Marchionatti A, Bohl L, Liaudat A, Picotto G, Rodríguez V, Narvaez C, Welsh J, Tolosa de Talamoni N. Buthionine-S,R-sulfoximine potentiates growth inhibition induced by 1,25(OH)2D3 on breast cancer cells with different phenotypes Bone. 53: 600. DOI: 10.1016/J.BONE.2012.12.022  0.451
2012 Bohl LP, Liaudat AC, Picotto G, Marchionatti AM, Narvaez CJ, Welsh J, Rodriguez VA, Tolosa de Talamoni NG. Buthionine sulfoximine and 1,25-dihydroxyvitamin D induce apoptosis in breast cancer cells via induction of reactive oxygen species. Cancer Investigation. 30: 560-70. PMID 22931489 DOI: 10.3109/07357907.2012.700985  0.573
2012 Welsh J. Vitamin D and cancer: integration of cellular biology, molecular mechanisms and animal models. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum. 243: 103-11. PMID 22536770 DOI: 10.3109/00365513.2012.682870  0.741
2012 Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Archives of Biochemistry and Biophysics. 523: 107-14. PMID 22085499 DOI: 10.1016/J.Abb.2011.10.019  0.742
2012 Whitcomb JP, Deagostino M, Ballentine M, Fu J, Tenniswood M, Welsh J, Cantorna M, McDowell MA. The Role of Vitamin D and Vitamin D Receptor in Immunity to Leishmania major Infection. Journal of Parasitology Research. 2012: 134645. PMID 22007288 DOI: 10.1155/2012/134645  0.63
2011 Teichert AE, Elalieh H, Elias PM, Welsh J, Bikle DD. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. The Journal of Investigative Dermatology. 131: 2289-97. PMID 21814234 DOI: 10.1038/jid.2011.196  0.575
2011 Welsh J. Vitamin D metabolism in mammary gland and breast cancer. Molecular and Cellular Endocrinology. 347: 55-60. PMID 21669251 DOI: 10.1016/J.Mce.2011.05.020  0.755
2011 Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Molecular Cancer. 10: 58. PMID 21592394 DOI: 10.1186/1476-4598-10-58  0.527
2011 Welsh J, Zinser LN, Mianecki-Morton L, Martin J, Waltz SE, James H, Zinser GM. Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor. Plos One. 6: e16479. PMID 21298063 DOI: 10.1371/Journal.Pone.0016479  0.826
2011 Bohl L, Liaudat A, Picotto G, Marchionatti A, Rodríguez V, Narvaez C, Welsh J, Tolosa de Talamoni N. Alterations in the viability, cell cycle and TRPV6 gene expression induced by calcitriol and BSO in breast cancer cells Bone. 49: 1377. DOI: 10.1016/J.Bone.2011.09.014  0.411
2010 Matthews D, LaPorta E, Zinser GM, Narvaez CJ, Welsh J. Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. The Journal of Steroid Biochemistry and Molecular Biology. 121: 362-7. PMID 20412854 DOI: 10.1016/j.jsbmb.2010.03.061  0.87
2010 Mordan-McCombs S, Brown T, Wang WL, Gaupel AC, Welsh J, Tenniswood M. Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status. The Journal of Steroid Biochemistry and Molecular Biology. 121: 368-71. PMID 20347977 DOI: 10.1016/J.Jsbmb.2010.03.062  0.581
2010 Milani C, Welsh J, Katayama ML, Lyra EC, Maciel MS, Brentani MM, Folgueira MA. Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment. The Journal of Steroid Biochemistry and Molecular Biology. 121: 151-5. PMID 20307664 DOI: 10.1016/J.Jsbmb.2010.03.051  0.634
2010 Zhi H, Hou S, Li R, Basir Z, Welsh J, Chen G. Abstract 1061A: Role of protein tyrosine phosphatase PTPH1 in breast cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-1061A  0.477
2009 Beildeck ME, Islam M, Shah S, Welsh J, Byers SW. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. Plos One. 4: e7872. PMID 19924301 DOI: 10.1371/Journal.Pone.0007872  0.486
2009 Costa JL, Eijk PP, van de Wiel MA, ten Berge D, Schmitt F, Narvaez CJ, Welsh J, Ylstra B. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. Bmc Genomics. 10: 499. PMID 19863778 DOI: 10.1186/1471-2164-10-499  0.634
2009 Korecki CL, Zinser G, Liu X, Siedler J, Welsh J, Niebur GL. Effect of the vitamin D receptor on bone geometry and strength during gestation and lactation in mice. Calcified Tissue International. 85: 405-11. PMID 19763375 DOI: 10.1007/S00223-009-9281-3  0.762
2009 Marchionatti AM, Picotto G, Narvaez CJ, Welsh J, Tolosa de Talamoni NG. Antiproliferative action of menadione and 1,25(OH)2D3 on breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 113: 227-32. PMID 19429426 DOI: 10.1016/J.Jsbmb.2009.01.004  0.613
2009 Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 150: 651-61. PMID 18845643 DOI: 10.1210/En.2008-1118  0.458
2009 Keith ME, LaPorta E, Welsh J. Abstract A52: Mechanisms of 1,25‐dihdyroxyvitamin D‐mediated growth arrest and apoptosis in transformed mammary cells Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A52  0.668
2009 Wang WW, Russell N, Chittur S, Ensslin C, Mordan‐McCombs S, Welsh J, Tenniswood M. Abstract A48: Genome‐wide analysis of the effects of 1α,25(OH)2D3on the action of bicalutamide in prostate cancer cells Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A48  0.541
2009 Matthews DG, Lloyd‐Coronado TM, Welsh J. Abstract A41: Impact of vitamin D receptor and the vitamin D hydroxylase CYP27B1 on morphology and gene expression in the mouse mammary gland Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A41  0.653
2008 Kemmis CM, Welsh J. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. Journal of Cellular Biochemistry. 105: 980-8. PMID 18767073 DOI: 10.1002/Jcb.21896  0.887
2008 Chlon TM, Taffany DA, Welsh J, Rowling MJ. Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. The Journal of Nutrition. 138: 1323-8. PMID 18567755 DOI: 10.1093/Jn/138.7.1323  0.656
2007 Welsh J. Targets of vitamin D receptor signaling in the mammary gland. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 22: V86-90. PMID 18290729 DOI: 10.1359/Jbmr.07S204  0.75
2007 Rowling MJ, Gliniak C, Welsh J, Fleet JC. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. The Journal of Nutrition. 137: 2608-15. PMID 18029472 DOI: 10.1093/Jn/137.12.2608  0.445
2007 Mordan-McCombs S, Valrance M, Zinser G, Tenniswood M, Welsh J. Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models. Nutrition Reviews. 65: S131-3. PMID 17867390 DOI: 10.1111/J.1753-4887.2007.Tb00341.X  0.86
2007 Welsh J. Vitamin D and prevention of breast cancer. Acta Pharmacologica Sinica. 28: 1373-82. PMID 17723171 DOI: 10.1111/J.1745-7254.2007.00700.X  0.76
2007 Valrance ME, Brunet AH, Welsh J. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo. Endocrinology. 148: 4887-94. PMID 17628009 DOI: 10.1210/En.2007-0267  0.88
2007 Mordan-McCombs S, Brown T, Zinser G, Welsh J, Tenniswood M. Dietary calcium does not affect prostate tumor progression in LPB-Tag transgenic mice. The Journal of Steroid Biochemistry and Molecular Biology. 103: 747-51. PMID 17307354 DOI: 10.1016/J.Jsbmb.2006.12.073  0.738
2007 Valrance ME, Brunet AH, Acosta A, Welsh J. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. Journal of Cellular Biochemistry. 101: 1505-19. PMID 17286279 DOI: 10.1002/Jcb.21263  0.887
2007 Li S, Byrne B, Welsh J, Palmer AF. Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers. Biotechnology Progress. 23: 278-85. PMID 17269699 DOI: 10.1021/bp060208  0.654
2007 Byrne B, Welsh J. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells. The Journal of Steroid Biochemistry and Molecular Biology. 103: 703-7. PMID 17254776 DOI: 10.1016/J.Jsbmb.2006.12.061  0.864
2007 Rowling MJ, Chlon TM, Matthews DG, Welsh J. Modulation of the endocytic partners megalin, cubilin, and disabled‐2 by retinoids and steroid hormones in human and mouse mammary epithelial cells The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A349-C  0.348
2007 Mordan‐McCombs S, Brown T, Maurice N, Welsh J, Tenniswood M. Loss of the Vitamin D Receptor Accelerates Prostate Tumor Progression in LPB‐Tag Transgenic Mice The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A255-C  0.541
2007 Monaco NA, Renouf M, Welsh J. Modulation of PXR and VDR Pathways by 1,25D and Bioactive Compounds of St. John's Wort and Soy in HepG2 Cells The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A110-B  0.499
2006 Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. The Journal of Nutrition. 136: 2754-9. PMID 17056796 DOI: 10.1093/Jn/136.11.2754  0.886
2006 Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. The Journal of Nutrition. 136: 887-92. PMID 16549446 DOI: 10.1093/Jn/136.4.887  0.882
2006 Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Molecular Cell. 21: 799-809. PMID 16543149 DOI: 10.1016/J.Molcel.2006.01.037  0.783
2005 Zinser GM, Suckow M, Welsh J. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. The Journal of Steroid Biochemistry and Molecular Biology. 97: 153-64. PMID 16111884 DOI: 10.1016/J.Jsbmb.2005.06.024  0.83
2005 Byrne BM, Welsh J. Altered thioredoxin subcellular localization and redox status in MCF-7 cells following 1,25-dihydroxyvitamin D3 treatment. The Journal of Steroid Biochemistry and Molecular Biology. 97: 57-64. PMID 16061374 DOI: 10.1016/J.Jsbmb.2005.06.023  0.825
2005 Zinser GM, Tribble E, Valrance M, Urben CM, Knutson JC, Mazess RB, Strugnell SA, Welsh J. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors. Anticancer Research. 25: 235-41. PMID 15816543  0.872
2005 Wietzke JA, Ward EC, Schneider J, Welsh J. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites. Molecular and Cellular Endocrinology. 230: 59-68. PMID 15664452 DOI: 10.1016/J.Mce.2004.11.001  0.863
2004 Welsh J. Vitamin D and breast cancer: insights from animal models. The American Journal of Clinical Nutrition. 80: 1721S-4S. PMID 15585794 DOI: 10.1093/Ajcn/80.6.1721S  0.747
2004 Zinser GM, Welsh J. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis. 25: 2361-72. PMID 15333467 DOI: 10.1093/Carcin/Bgh271  0.807
2004 Zinser GM, Welsh J. Effect of Vitamin D3 receptor ablation on murine mammary gland development and tumorigenesis. The Journal of Steroid Biochemistry and Molecular Biology. 89: 433-6. PMID 15225815 DOI: 10.1016/J.Jsbmb.2004.03.012  0.854
2004 Valrance ME, Welsh J. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor. The Journal of Steroid Biochemistry and Molecular Biology. 89: 221-5. PMID 15225775 DOI: 10.1016/J.Jsbmb.2004.03.082  0.889
2004 Zinser GM, Welsh J. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Molecular Endocrinology (Baltimore, Md.). 18: 2208-23. PMID 15178742 DOI: 10.1210/Me.2003-0469  0.869
2004 Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C, Cramer SD. Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Research. 64: 2143-7. PMID 15026355 DOI: 10.1158/0008-5472.Can-03-3480  0.703
2003 Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. Vitamin D-3 receptor as a target for breast cancer prevention. The Journal of Nutrition. 133: 2425S-2433S. PMID 12840219 DOI: 10.1093/Jn/133.7.2425S  0.856
2003 Narvaez CJ, Byrne BM, Romu S, Valrance M, Welsh J. Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 Vitamin D3-resistant variant can be sensitized by TPA. The Journal of Steroid Biochemistry and Molecular Biology. 84: 199-209. PMID 12711004 DOI: 10.1016/S0960-0760(03)00029-3  0.871
2003 Flanagan L, Packman K, Juba B, O'Neill S, Tenniswood M, Welsh J. Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. The Journal of Steroid Biochemistry and Molecular Biology. 84: 181-92. PMID 12711002 DOI: 10.1016/S0960-0760(03)00028-1  0.843
2003 Wietzke JA, Welsh J. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 84: 149-57. PMID 12710998 DOI: 10.1016/S0960-0760(03)00024-4  0.882
2003 Zinser GM, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Molecular and Cellular Endocrinology. 200: 67-80. PMID 12644300 DOI: 10.1016/S0303-7207(02)00416-1  0.857
2002 Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B, Narvaez CJ. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 83: 85-92. PMID 12650704 DOI: 10.1016/S0960-0760(02)00277-7  0.85
2002 Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 23: 2103-9. PMID 12507934 DOI: 10.1093/Carcin/23.12.2103  0.808
2002 Zinser G, Packman K, Welsh J. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development (Cambridge, England). 129: 3067-76. PMID 12070083  0.875
2001 Narvaez CJ, Zinser G, Welsh J. Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids. 66: 301-8. PMID 11179738 DOI: 10.1016/S0039-128X(00)00202-6  0.87
2000 Narvaez CJ, Welsh J. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. The Journal of Biological Chemistry. 276: 9101-7. PMID 11053435 DOI: 10.1074/Jbc.M006876200  0.596
2000 Byrne IM, Flanagan L, Tenniswood MP, Welsh J. Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology. 141: 2829-36. PMID 10919269 DOI: 10.1210/Endo.141.8.7618  0.489
2000 Kiley SC, Welsh J, Narvaez CJ, Jaken S. Protein kinase C isozymes and substrates in mammary carcinogenesis. Journal of Mammary Gland Biology and Neoplasia. 1: 177-87. PMID 10887491 DOI: 10.1007/Bf02013641  0.399
2000 Flanagan L, Van Weelden K, Ammerman C, Ethier SP, Welsh J. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Research and Treatment. 58: 193-204. PMID 10718481 DOI: 10.1023/A:1006331716981  0.434
1998 Welsh J, VanWeelden K, Flanagan L, Byrne I, Nolan E, Narvaez CJ. The role of vitamin D3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Sub-Cellular Biochemistry. 30: 245-270. PMID 9932518 DOI: 10.1007/978-1-4899-1789-8_11  0.359
1998 VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology. 139: 2102-10. PMID 9528999 DOI: 10.1210/Endo.139.4.5892  0.647
1998 Welsh J. Vitamin D compounds as potential therapeutics for estrogen-independent breast cancer. Nutrition (Burbank, Los Angeles County, Calif.). 13: 915-7. PMID 9357033 DOI: 10.1016/S0899-9007(97)00258-X  0.607
1998 Nolan E, Donepudi M, VanWeelden K, Flanagan L, Welsh J. Molecular and Cellular Biochemistry. 188: 13-20. DOI: 10.1023/A:1006879213501  0.702
1997 Narvaez CJ, Welsh J. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant. Endocrinology. 138: 4690-8. PMID 9348195 DOI: 10.1210/Endo.138.11.5545  0.714
1997 Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Research and Treatment. 42: 31-41. PMID 9116316 DOI: 10.1023/A:1005772432465  0.712
1996 Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J. 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 58: 367-76. PMID 8903420 DOI: 10.1016/0960-0760(96)00055-6  0.686
1996 Narvaez CJ, Vanweelden K, Byrne I, Welsh J. Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology. 137: 400-9. PMID 8593782 DOI: 10.1210/Endo.137.2.8593782  0.716
1995 Welsh J, Simboli-Campbell M, Narvaez CJ, Tenniswood M. Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Advances in Experimental Medicine and Biology. 375: 45-52. PMID 7645427 DOI: 10.1007/978-1-4899-0949-7_4  0.739
1994 Gagnon AM, Simboli-Campbell M, Welsh JE. Induction of calbindin D-28K in Madin-Darby bovine kidney cells by 1,25(OH)2D3. Kidney International. 45: 95-102. PMID 8127026 DOI: 10.1038/Ki.1994.11  0.626
1994 Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens Biochemistry and Cell Biology. 72: 537-545. PMID 7654327 DOI: 10.1139/O94-072  0.724
1993 Weaver VM, Welsh J. 1,25-Dihydroxycholecalciferol supplementation prevents hypocalcemia in magnesium-deficient chicks Journal of Nutrition. 123: 764-771. PMID 8463878 DOI: 10.1093/Jn/123.4.764  0.723
1992 Simboli-Campbell M, Franks DJ, Welsh J. 1,25(OH)2D3 increases membrane associated protein kinase C in MDBK cells. Cellular Signalling. 4: 99-109. PMID 1315148 DOI: 10.1016/0898-6568(92)90011-V  0.646
1992 Simboli-Campbell M, Gagnon AM, Franks DJ, Welsh J. TPA decreases 1,25(OH)2D3 binding and calbindin D-28K in renal (MDBK) cells. Molecular and Cellular Endocrinology. 83: 143-51. PMID 1312489 DOI: 10.1016/0303-7207(92)90155-Y  0.634
1991 Welsh J, Weaver V, Simboli-Campbell M. Regulation of renal 25(OH)D3 1 alpha-hydroxylase: signal transduction pathways Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 69: 768-770. PMID 1667975 DOI: 10.1139/O91-118  0.659
1989 Weaver VM, Welsh JJ. Vitamin D metabolism in magnesium deficient chicks Nutrition Research. 9: 1363-1369. DOI: 10.1016/S0271-5317(89)80161-7  0.558
Show low-probability matches.